This bulletin article applies to NC Medicaid Direct and NC Medicaid Managed Care.
A new clinical coverage policy (CCP) will provide coverage for U.S. Food & Drug Administration (FDA) approved cell and gene therapies effective Jan. 1, 2025. Please consult CCP 1S-13 located on the NC Medicaid Program Specific Clinical Coverage webpage for detailed information regarding this new policy.
For beneficiaries enrolled in a managed care plan, providers should contact the appropriate health plan for that beneficiary.
Contact
NCTracks Call Center: 800-688-6696
NC Managed Care health plans